Active substanceDextran [average molecular weight 35,000-45,000]Dextran [average molecular weight 35,000-45,000]
Similar drugsTo uncover
  • Dextran 40
    solution d / infusion 
    EAST-FARM, CJSC     Russia
  • Reopoliglukin
    solution d / infusion 
  • Reopoliglyukin-40
    solution d / infusion 
    GROTEKS, LLC     Russia
  • Reopoliglyukin-40
    solution d / infusion 
  • Reopoliglyukin-40
    solution d / infusion 
    MAKSFARM, OJSC     Russia
  • Reopoliglyukin-40
    solution d / infusion 
    MOSFARM, OJSC     Russia
  • Reopoliglyukin-40
    solution d / infusion 
  • Reopoliglyukin-40-Eskom
    solution d / infusion 
    ESKOM NPK, OAO     Russia
  • Rheopolidex®
    solution d / infusion 
    BIOSINTEZ, PAO     Russia
  • Dosage form: & nbspsolution for infusions
    Composition:

    Dextran 40, medium MM 35000-45000 - 100 g;

    Excipients: sodium chloride - 9 grams, water for injection - up to 1 liter.

    Description:

    Reopoliks is a colorless or slightly yellowish transparent liquid.

    Pharmacotherapeutic group:plasma-substituting agent
    ATX: & nbsp

    B.05.A.A   Blood plasma preparations and plasma-substituting drugs

    Pharmacodynamics:

    Blood substitute, increases the suspension stability of blood, reduces its viscosity, restores blood flow in small capillaries, normalizes arterial and venous circulation, prevents and reduces the aggregation of blood elements, exerts detoxification effect.

    By the osmotic mechanism it stimulates diuresis (it is filtered in the glomeruli, creates high oncotic pressure in the primary urine and prevents reabsorption of water in the tubules), which promotes (and accelerates) the excretion of poisons, toxins, degradation products of metabolism.

    The pronounced vollemic effect positively affects hemodynamics and is simultaneously accompanied by the washing out of metabolic products from the tissues, which, together with an increase in diuresis, provides an accelerated detoxification of the organism.

    With a rapid introduction, the plasma volume can be increased by a factor of 2 compared with the volume of the injected drug, Each gram of dextrose polymer with a molecular weight of 30,000-40000 contributes to the redistribution of 20-25 ml of fluid from tissues into the bloodstream. It is pyrogen-free, non-toxic.

    Pharmacokinetics:

    The elimination half-life is 6 hours, it is excreted by the kidneys, 70% are excreted through the kidneys within 24 hours, 30% goes to the RES, the liver where the enzyme is digested with acidic alpha-glucosidase to glucose, but is not a source of carbohydrate nutrition.

    Indications:

    To improve capillary blood flow and replenish the volume of circulating blood; traumatic, burn, hemorrhagic, postoperative,cardiogenic and toxic shock (prevention and treatment).

    Substitution of plasma volume for blood loss in pediatrics.

    To improve arterial and venous circulation (prevention and treatment): thrombosis, thrombophlebitis, obliterating endarteritis, Raynaud's disease.

    To improve microcirculation and reduce the risk of thrombus formation in the graft in vascular and plastic surgery.

    For detoxification: peritonitis, pancreatitis, ulcerative-necrotic enterocolitis, food toxic infections, extensive purulent-necrotic processes of soft tissues, crash syndrome, "inclusion" syndrome.

    For hemodilution in the preoperative period.

    Conducting therapeutic plasmapheresis to replace the removed volume of plasma.

    To be added to perfusion fluid in cardiopulmonary bypass in cardiac surgery.

    Diseases of the retina and optic nerve (complicated high degree myopathy, mesh sheath dystrophy, retinal vascular (venous) pathology, initial atrophy), inflammatory diseases of the cornea and the choroid of the eye.

    Contraindications:

    Hypersensitivity, thrombocytopenia, chronic renal failure (anuria), heart failure, etc.Conditions in which the introduction of large volumes of fluid is contraindicated.

    Electrophoresis is contraindicated in the maceration of the skin of the eyelids, abundant mucoid-purulent discharge.

    Dosing and Administration:

    Individual, determined by the patient's condition, the value of blood pressure, heart rate, hematocrit.

    Intravenously sprayed, drip-drip and drip. Doses and the speed of administration of the drug should be selected individually, in accordance with the indications and condition of the patient.

    Immediately before the use of the drug, with the exception of urgent cases, cutaneous test. To do this, after treatment with ethanol at the injection site in the middle of the inner surface of the forearm, 0.05 ml is injected intradermally to form a lemon crust. The presence of redness in the injection site with a diameter of more than 1.5 mm,pools or the appearance of symptoms of the general reaction of the organism in the form of nausea, dizziness and other manifestations 10-15 min after injection, indicates a hypersensitivity of the patient to the drug (risk group).

    When using rheopolyglucin, bioassays: after slow administration of the first 5 drops of the drug, the transfusion is stopped for 3 minutes, then another 30 drops are introduced and the infusion is again stopped for 3 minutes. In the absence of a reaction, the administration of the drug continues. The results of the bioassay are necessarily recorded in the medical history.

    1. When there is a violation of capillary blood flow (various forms of shock) injected / drip or jet-drip, in a dose of 500 to 1500 ml, to stabilize the hemodynamic parameters in a life-sustaining level. If necessary, the amount of the drug can be increased to 2000 ml.

    Children with various forms of shock are administered at the rate of 5-10 ml / kg, the dose can be increased if necessary to 15 ml / kg. It is not recommended to reduce the hematocrit value below 25%.

    2. With cardiovascular and plastic operations injected / drip immediately before surgery, for 30-60 minutes in adults and children in doses of 10 ml / kg during operation adults - 500 ml for children - 15 ml / kg. After surgery, the drug is administered / drip (for 60 minutes) for 5-6 days at: adults - 10 ml / kg, single dose, for children up to 2-3 years - 10 ml / kg once a day for children to 8 years-7-10 ml / kg 1-2 times a day, children under 13 years-5-7 ml / kg 1-2 times a day. For children older than 14 years, the doses are the same as for adults.

    3. In operations with artificial circulation the drug is added to the blood at a rate of 10-20 ml / kg of the patient to fill the oxygenator pump. The concentration of reopolyglucin in the perfusion solution should not exceed 3%. In the postoperative period, the doses of the drug are the same as for a violation of capillary blood flow.

    4. With the aim of detoxification injected / drip in a single dose of 500 to 1250 ml (in children 5-10 ml / kg) for 60-90 minutes. If necessary, you can pour another 500 ml of the drug in the first day (in children the administration of the drug in the first day can be repeated in the same doses). In the following days, the drug is administered drip, adults in a daily dose of 500 ml, children - at a rate of 5-10 ml / kg. Together, it is advisable to introduce crystalloid solutions (Ringer and Ringer-acetate, etc.), in such an amount as to normalize the water-electrolyte balance (especially important in the treatment of dehydrated patients and after surgical operations), reopolyglucinum, as a rule, causes an increase in diuresis indicates dehydration of the patient's body).

    5. In ophthalmic practice is applied by electrophoresis, which is carried out in a conventional manner.The drug consumption per procedure is 10 ml. The procedure is carried out once a day, injected from both the positive and negative pole. The current density is up to 1.5 mA / cm2. The duration of the procedure is 15-20 min. The course of treatment consists of 5-10 procedures.

    Side effects:

    Allergic reactions, anaphylactic reactions are possible with the development of collapse.

    Can provoke bleeding, the development of acute renal failure.

    Special instructions:

    Together with the drug, it is advisable to administer crystalloid solutions (isotonic sodium chloride solution, 5% dextrose (glucose) solution) To fill and maintain liquid and electrolyte balance. This is especially important in the treatment of dehydrated patients and after severe surgical operations.

    Causes an increase in diuresis (if there is a decrease in diuresis with the release of viscous syrupy urine, this may indicate dehydration). In this case, it is necessary to introduce / into colloidal solutions to replenish and maintain the water-electrolyte balance.

    In patients with reduced filtration capacity of the kidneys, it is necessary to limit the administration of sodium chloride.

    Dextrins are able to envelop the surface of erythrocytes, preventing the determination of the blood group, so it is necessary to use washed red blood cells.

    Form release / dosage:Solution for infusion, 100 mg / ml.
    Packaging:

    200 ml and 400 ml in bottles of blood glass transfusion and infusion preparations.

    Storage conditions:

    In a dry place inaccessible to children, at a temperature of 10 to 30 ° C.

    Freezing during transportation is allowed.
    Shelf life:

    2 years.

    Do not use after the expiration date.

    Terms of leave from pharmacies:On prescription
    Registration number:P N002530 / 01-2003
    Date of registration:17.04.2008
    The owner of the registration certificate:BIOSINTEZ, PAO BIOSINTEZ, PAO Russia
    Manufacturer: & nbsp
    Representation: & nbspBIOSINTEZ JSC BIOSINTEZ JSC Russia
    Information update date: & nbsp10.01.2016
    Illustrated instructions
      Instructions
      Up